Phase I trial of intravenous WX 554 in healthy volunteers.

Trial Profile

Phase I trial of intravenous WX 554 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2010

At a glance

  • Drugs WX 554 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Jun 2010 Status changed to completed, based on information presented in a WILEX media release.
    • 07 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top